Corporate Membership

COA accepts corporate members as part of its mission to unite the cancer community in order to enhance the quality of cancer care. The purpose of the corporate member program is two-fold :

  • Foster enhanced communications between community oncology and corporate members (pharmaceutical companies, GPO/distributors, etc) to improve the cancer care delivery system
  • Provide a forum for addressing common issues (not specific brands/products or product-specific issues) that impact patient care delivery

Onyx Pharmaceuticals

Spectrum Pharmaceuticals

Taiho Pharmaceuticals

Takeda Pharmaceuticals

Teva Pharmaceuticals USA



Community Oncology Alliance
1101 Pennsylvania Avenue, N.W.
Suite 700
Washington, DC 20004
(202) 756-2258